A6542112
Obatoclax Mesylate , ≥97% , 803712-79-0
CAS NO.:803712-79-0
Empirical Formula: C20H19N3O.CH4O3S
Molecular Weight: 413.49
MDL number: MFCD18074508
EINECS: 804-325-6
| Pack Size | Price | Stock | Quantity |
| 5MG | RMB625.60 | In Stock |
|
| 10MG | RMB1386.40 | In Stock |
|
| 50MG | RMB4103.20 | In Stock |
|
| others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
| storage temp. | -20°C |
| solubility | Soluble in DMSO (up to 5 mg/ml). |
| form | solid |
| color | Purple |
| Stability: | Stable for 2 years from date of purchase as supplied. Solutions in DMSO may be stored at -20° for up to 3 months. |
| InChI | 1S/C20H19N3O.CH4O3S/c1-12-8-13(2)21-16(12)10-19-20(24-3)11-18(23-19)17-9-14-6-4-5-7-15(14)22-17;1-5(2,3)4/h4-11,21-22H,1-3H3;1H3,(H,2,3,4)/b19-10-; |
| InChIKey | ZFKXDVMHNXPEIY-PEZBNFGJSA-N |
| SMILES | O=S(O)(C)=O.CC1=C(NC(C)=C1)/C=C2N=C(C3=CC4=C(N3)C=CC=C4)C=C\2OC |
Description and Uses
Obatoclax (803712-79-0) is a novel Bcl-2 homology domain-3 (BH3) mimetic.1?Inhibits primary acute myeloid leukemia (AML) progenitor cell proliferation (IC50=0.18 μM) and induces apoptosis in primary AML cells (IC50= 3.6 μM).2?Obatoclax synergizes with other agents such as chloroquine3?and cytarabine4?in cytotoxicity against a variety of cancer cells.
Obatoclax (GX15-070) is an inhibitor of Bcl-2 with Ki of 0.22 μM.
Safety
| Symbol(GHS) | ![]() GHS06 |
| Signal word | Danger |
| Hazard statements | H315-H301 |
| Precautionary statements | P264-P280-P302+P352-P321-P332+P313-P362-P264-P270-P301+P310-P321-P330-P405-P501 |
| WGK Germany | WGK 3 |
| Storage Class | 6.1C - Combustible acute toxic Cat.3 toxic compounds or compounds which causing chronic effects |
| Hazard Classifications | Acute Tox. 3 Oral Skin Irrit. 2 |




